Category:
Description:
Indications:
Drug
interactions:
-
Reduced
efficacy: clindamycin,
lincomycin
-
Reduced
bioavailability of tablets (capsules not affected): digioxin
-
Reduced
plasma concentrations: quinidine
Precautions:
Adverse
Reactions (Side Effects):
|
Dosage:
Administered
orally as a suspension
|
The information contained here is an abbreviated summary. For more detailed
and complete information, consult the manufacturer's product information sheets
or standard textbooks. Source:
Operational Medicine 2001, Health
Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau
of Medicine and Surgery, Department
of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300
OB-GYN 101:
Introductory Obstetrics & Gynecology
© 2003, 2004, 2005, 2008
Medical Education Division,
Brookside Associates, Ltd.
All rights reserved
|